Skeletal deformity company raises $5.8M: 4 insights

Surface Technology

Synoste raised $5.8 million to launch its smart skeletal deformation correction technology for orthopedic and spine applications.

Here are four things to know:

1. Lifeline Ventures and AO Invest, an investment fund backed by the AO Foundation, provided the funds.

2. Existing investors, such as HTGF, also participated in the funding round.

3. The Lifeline and AO investment brings the total equity invested into Synoste to $11.4 million.

4. Synoste is a Finland-based company that develops bone deformity solutions.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers